Page 19 - Hematology_ Basic Principles and Practice ( PDFDrive )

xvi Contributors

Francesco M. Marincola, MD Jeffrey S. Miller, MD
Chief Research Officer, Research Branch, Sidra Medical and Professor of Medicine, Division of Hematology, Oncology, and
Research Center; Professor of Medicine, Weill Cornell Medical Transplantation, University of Minnesota, Minneapolis, Minnesota
College, Doha, Qatar Natural Killer Cell-Based Therapies
Human Leukocyte Antigen and Human Neutrophil Antigen Systems
Martha P. Mims, MD, PhD
John Mascarenhas, MD Professor and Chief, Section of Hematology Oncology, Internal
Associate Professor of Medicine, The Tisch Cancer Institute, Icahn Medicine, Baylor College of Medicine, Houston, Texas
School of Medicine at Mount Sinai, New York, New York Lymphocytosis, Lymphocytopenia, Hypergammaglobulinemia, and
The Polycythemias Hypogammaglobulinemia
Essential Thrombocythemia
Primary Myelofibrosis Traci Heath Mondoro, PhD
Alternate Representative Branch Chief, NHLBI Translational Blood
Steffen Massberg, MD Science and Resources Branch, Division of Blood Diseases and
Professor of Cardiology, German Heart Center Munich, Technical Resources, National Heart, Lung, and Blood Institute, National
University of Munich, Munich, Germany Institutes of Health, Bethesda, Maryland
Chemokines and Hematopoietic Cell Trafficking Investigational New Drug–Enabling Processes for Cell-Based Therapies
Rodger P. McEver, MD Paul Moorehead, MD
Member and Chair, Cardiovascular Biology Research Program, Section of Pediatric Hematology/Oncology, Janeway Children’s
Oklahoma Medical Research Foundation, Oklahoma City, Health and Rehabilitation Centre; Clinical Assistant Professor,
Oklahoma Discipline of Pediatrics, Faculty of Medicine, Memorial University,
Cell Adhesion St. John’s, Newfoundland and Labrador, Canada
Hemophilia A and B
Emer McGrath, MB, PhD
Brigham and Women’s Hospital, Massachusetts General Hospital, Luciana R. Muniz, MD
Harvard Medical School, Boston, Massachusetts PhD Student, Icahn School of Medicine at Mount Sinai, Division
Stroke of Hematology and Oncology, Tisch Cancer Institute, New York,
New York
Matthew S. McKinney, MD Dendritic Cell Biology
Instructor in Medicine, Department of Medicine, Division of
Hematologic Malignancies, Duke University School of Medicine, Nikhil C. Munshi, MD
Durham, North Carolina Associate Director, Jerome Lipper Multiple Myeloma Center, Dana-
Origin of Non-Hodgkin Lymphoma Farber Cancer Institute; Physician, Hematology/Oncology and
Medicine, Boston VA Healthcare System; Associate Professor of
Rohtesh S. Mehta, MD, MPH, MS Medicine, Harvard Medical School, Boston, Massachusetts
Assistant Professor of Medicine, Stem Cell Transplantation and Plasma Cell Neoplasms
Cellular Therapy, The University of Texas MD Anderson Cancer
Center, Houston, Texas Vesna Najfeld, PhD
Unrelated Donor Cord Blood Transplantation for Hematologic Professor of Pathology and Medicine, Director, Tumor
Malignancies CytoGenomic Laboratory, Icahn School of Medicine at Mount
Sinai, New York, New York
William C. Mentzer, MD Conventional and Molecular Cytogenomic Basis of Hematologic
Professor Emeritus, Pediatrics, University of California, San Malignancies
Francisco, San Francisco, California The Polycythemias
Extrinsic Nonimmune Hemolytic Anemias Essential Thrombocythemia
Primary Myelofibrosis
Giampaolo Merlini, MD
Director, Amyloidosis Research and Treatment Center, Foundation Lalitha Nayak, MD
IRCCS Policlinico San Matteo, Department of Molecular Assistant Professor in Hematology and Oncology Medicine, Case
Medicine, University of Pavia, Pavia, Italy Western Reserve University School of Medicine, Cleveland, Ohio
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma Anemia of Chronic Diseases

Reid Merryman, MD Ishac Nazy, PhD
Clinical Fellow, Dana-Farber/Partners CancerCare Hematology/ Associate Professor of Medicine, Michael G. DeGroote School of
Oncology Fellowship Program, Boston, Massachusetts Medicine, McMaster University, Hamilton, Ontario, Canada
Immune Checkpoint Blockade in Hematologic Malignancies Diseases of Platelet Number: Immune Thrombocytopenia, Neonatal
Alloimmune Thrombocytopenia, and Posttransfusion Purpura
Marc Michel, MD
Department of Internal Medicine, National Referral Center for Anne T. Neff, MD
Adult Immune Cytopenias, Henri Mondor University Hospital, Professor of Medicine, Cleveland Clinic Lerner College of
Assistance Publique Hopitaux de Paris, Creteil, France Medicine; Staff Physician, Cleveland Clinic Foundation, Cleveland,
Autoimmune Hemolytic Anemia Ohio
Rare Coagulation Factor Deficiencies
Anna Rita Migliaccio, PhD
Professor, The Tisch Cancer Institute, Icahn School of Medicine Paul M. Ness, MD
at Mount Sinai, New York, New York; Professor of Biological and Director, Transfusion Medicine, The Johns Hopkins Hospital;
Neurological Sciences, Alma Mater University, Bologna, Italy Professor of Pathology and Medicine, The Johns Hopkins
Biology of Erythropoiesis, Erythroid Differentiation, and Maturation University School of Medicine, Baltimore, Maryland
Principles of Red Blood Cell Transfusion